Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.


Clinical Trial Description

The goal of this proposed study is to investigate the potential utility of combined analysis of parameters (Ktrans, ti and ADC) in discriminating benign from malignant salivary glands tumors (SGTs). A total of 30 treatment naïve patients suspicious of SGT as observed on clinical evaluation and prior routine CT, MRI, Ultrasound, FNAC and/or PET will undergo 3T MRI. The MRI protocol will include acquisition of anatomical images with and without contrast agent injection, diffusion imaging and dynamic contrast enhanced-MRI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04452162
Study type Interventional
Source Abramson Cancer Center at Penn Medicine
Contact Marisa Sanchez
Phone 2159019994
Email Marisa.Sanchez@pennmedicine.upenn.edu
Status Recruiting
Phase N/A
Start date August 25, 2020
Completion date July 2024

See also
  Status Clinical Trial Phase
Completed NCT04970875 - Partial Modified Blair Incision on Benign Tumor Parotidectomy Scar's Characteristics
Completed NCT03602079 - Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Phase 1/Phase 2
Recruiting NCT06047236 - Immune Biomarker Study for Salivary Gland Carcinoma
Active, not recruiting NCT05581979 - PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
Active, not recruiting NCT04249947 - P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) Phase 1
Completed NCT06034782 - Diagnostic Accuracy of Fine Needle Aspiration in Patients With Salivary Gland Tumors.